Showing results (171-180 of 601) with videos related to
Sort By:
Pageof 61
Multiple Sclerosis and Related Disorders|April 18, 2020
Meeting report: "Human endogenous retroviruses: HERVs or transposable elements in autoimmune, chronic inflammatory and degenerative diseases or cancer", Lyon, France, november 5th and 6th 2019 - an MS scientist's digestDavid Kremer, Vivien Weyers, Joel Gruchot, et al.Muscle & Nerve|July 22, 2004
Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous systemBernd C Kieseier, Reinhard Kiefer, Ralf Gold, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 17, 2015
Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage ("Neuroprotection")Heinz Wiendl, Christian Elger, Hans Förstl, et al.Journal of Neuroimmunology|April 2, 2003
CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous systemStefan Kastenbauer, Uwe Koedel, Manfred Wick, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2018
Secretome analysis of nerve repair mediating Schwann cells reveals Smad-dependent trophismJessica Schira, André Heinen, Gereon Poschmann, et al.Neurological Research and Practice|December 16, 2020
An unmet clinical need: roads to remyelination in MSPeter Göttle, Moritz Förster, Vivien Weyers, et al.The European Journal of Neuroscience|March 7, 2024
Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosisKateřina Klíčová, Jan Mareš, Ondřej Sobek, et al.Cytokine|February 21, 2012
Ex vivo activation of naturally occurring IL-17-producing T cells does not require IL-6Vsevolod Smolianov, Thomas Dehmel, Bernd C Kieseier, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 22, 2021
Electrophysiological predictors of response to subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathyMonica Alcantara, Hans-Peter Hartung, John-Philip Lawo, et al.Muscle & Nerve|July 22, 2008
The metalloproteinase-disintegrin ADAM10 is exclusively expressed by type I muscle fibersThomas Dehmel, Hans Hilmar Goebel, Hans-Peter Hartung, et al.Pageof 61